Shrinking Territory: Patent Eligibility of Biotechnological Inventions

Today's General Counsel
December/January 2015

This article explores the potential, perhaps unintended, consequences of a broad interpretation of Mayo and Myriad on patent eligibility of biotechnology and life sciences inventions under Section 101, and the effect of those consequences on biotechnology innovation.

View Attachment (PDF)